Insider Stock Trading History of Bowden Christopher


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bowden Christopher since year 2005. The trader's CIK number is 1608601. At the time of this reporting, Bowden Christopher is the Chief Medical Officer of Agios Pharmaceuticals Inc . (stock ticker symbol AGIO). See this page for all insider trading activities at Agios Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Bowden Christopher since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-11 AGIO Agios Pharmaceuticals Inc Option Ex 6,000 35.16 210,959
2017-09-11 AGIO Agios Pharmaceuticals Inc Sale 6,000 65.00 390,000
2015-06-01 AGIO Agios Pharmaceuticals Inc Option Ex 5,000 35.16 175,799
2015-06-01 AGIO Agios Pharmaceuticals Inc Sale 5,000 120.67 603,350

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bowden Christopher (Chief Medical Officer of Agios Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.